NEUROPACE, INC. (NPCE) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 17.43M USD | Liabilities, Current |
| Cash and equivalents | 12.54M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 14.93M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 18.11M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $17.43M | $12.54M | (m) | $14.93M | $18.11M | (m) |
| 2026-03-31 | (m) | $16.17M | $14.78M | (m) | $14.79M | $16.69M | (m) |
| 2025-12-31 | (m) | $17.81M | $21.69M | (m) | $14.68M | $16.90M | (m) |
| 2025-09-30 | (m) | $19.61M | $20.65M | (m) | $14.94M | $18.14M | (m) |
| 2025-06-30 | (m) | $17.14M | $22.86M | (m) | $13.55M | $16.35M | (m) |
| 2025-03-31 | (m) | $14.71M | $27.02M | (m) | $15.44M | $13.58M | (m) |
| 2024-12-31 | (m) | $15.16M | $13.43M | (m) | $12.85M | $13.38M | (m) |
| 2024-09-30 | (m) | $14.78M | $15.42M | (m) | $11.56M | $12.08M | (m) |
| 2024-06-30 | (m) | $12.59M | $12.84M | (m) | $11.24M | $11.36M | (m) |
| 2024-03-31 | (m) | $13.11M | $13.00M | (m) | $11.63M | $11.42M | (m) |
| 2023-12-31 | (m) | $16.23M | $18.06M | (m) | $12.31M | $11.21M | (m) |
| 2023-09-30 | (m) | $12.81M | $9.72M | (m) | $11.28M | $9.76M | (m) |
| 2023-06-30 | (m) | $11.51M | $7.86M | (m) | $10.88M | $10.01M | (m) |
| 2023-03-31 | (m) | $9.88M | $6.72M | (m) | $9.19M | $10.75M | (m) |
| 2022-12-31 | (m) | $10.98M | $6.61M | (m) | $7.48M | $9.71M | (m) |
| 2022-09-30 | $93.29M | $9.42M | $5.69M | $79.72M | $7.88M | $8.58M | 9.91× |
| 2022-06-30 | $100.89M | $11.40M | $5.70M | $86.71M | $8.47M | $8.42M | 8.85× |
| 2022-03-31 | $112.24M | $12.06M | $7.49M | $95.69M | $9.06M | $8.10M | 9.31× |
| 2021-12-31 | (m) | $9.30M | $19.19M | (m) | $7.09M | $7.82M | (m) |
| 2021-09-30 | $129.94M | $8.67M | $26.63M | $96.70M | $6.61M | $7.16M | 14.98× |
| 2021-06-30 | $135.62M | $7.61M | $31.25M | $96.67M | $7.71M | $6.96M | 17.82× |
| 2021-03-31 | $38.73M | $10.81M | $13.84M | $16.69M | $8.20M | $7.04M | 3.58× |
| 2020-12-31 | $46.47M | $9.60M | $26.39M | $11.69M | $8.39M | $6.91M | 4.84× |
| 2020-09-30 | (m) | (m) | $43.14M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $9.62M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |